Analytical Data
-
基因名
Eef1akmt2
- Application
-
别名
EEF1A lysine methyltransferase 2(EC 2.1.1.-)(Methyltransferase-like protein 10)(Protein-lysine N-methyltransferase Mettl10)
-
种属
Mouse
-
表达系统
E. coli
-
标签
N- His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9D853
-
表达区间
1-244aa
-
分子量
32.9 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Eef1akmt2, also known as Eukaryotic Translation Elongation Factor 1 Alpha Kinase 2, is a gene that encodes a protein involved in the regulation of protein synthesis. It is a member of the EEF1A family and plays a critical role in the translation process by modifying elongation factors, which are essential for the accurate and efficient synthesis of proteins. Recent studies have highlighted Eef1akmt2's potential involvement in various cellular processes, including stress response and cell proliferation. Additionally, the dysregulation of its expression has been linked to several diseases, particularly cancers, where altered protein synthesis is a hallmark. This has prompted researchers to investigate the functional properties and regulatory mechanisms of Eef1akmt2 through recombinant protein techniques. Generating recombinant Eef1akmt2 allows for detailed exploration of its structure-function relationship, interaction with other cellular components, and its role in translational control. Understanding these aspects is crucial for developing targeted therapies that could modulate its activity in pathological conditions. Therefore, Eef1akmt2 has emerged as a significant focal point in molecular biology and cancer research, encouraging further studies to elucidate its potential as a therapeutic target.
